|
No
|
Name of the test
|
Maximum days to report
|
If it can be done in emergency situation in
few hours
|
Tube
|
Method
|
|
1
|
PT,INR
|
1
|
YES
|
PT & PTT
|
Functional
(One stage method,clotting)
|
|
2
|
PTT
|
1
|
YES
|
PT & PTT
|
Functional
(One stage method,clotting)
|
|
3
|
V.W.F
|
7
|
NO
|
PT & PTT
|
Functional
(One stage method,colorimetric)
|
|
4
|
V.W.F Activity (Ricof)
|
7
|
NO
|
PT & PTT
|
Functional
|
|
5
|
Protein C
|
7
|
NO
|
PT & PTT
|
Functional
(One stage method,colorimetric)
|
|
6
|
Protein S
|
7
|
NO
|
PT & PTT
|
Functional
(One stage method,clotting)
|
|
7
|
Anti thrombin III
|
7
|
NO
|
PT & PTT
|
Functional
(One stage method,colorimetric)
|
|
8
|
APCR(FV leiden)
|
7
|
NO
|
PT & PTT
|
Functional
(One stage method,clotting)
|
|
9
|
Homocystein
|
7
|
NO
|
Clot
|
ELISA
|
|
10
|
Lupus Anti coagulant screen (LAC)
|
7
|
NO
|
PT & PTT
|
Functional
(One stage method,clotting)
|
|
11
|
Lupus Anti coagulant confirm (LAC
confirm)
|
7
|
NO
|
PT & PTT
|
Functional
(One stage method,clotting)
|
|
12
|
Fibrinogen
|
1
|
NO
|
PT & PTT
|
Functional
(One stage method,clotting)
|
|
13
|
D-Dimer
|
1
|
YES
|
PT & PTT
|
ELFA
|
|
14
|
FDP
|
1
|
YES
|
PT & PTT
|
Agglutination
|
|
15
|
Factor XIII
|
2
|
NO
|
PT & PTT
|
Qualitative
|
|
16
|
Factor XII
|
7
|
NO
|
PT & PTT
|
Functional
(One stage method,clotting)
|
|
17
|
Factor XI
|
7
|
NO
|
PT & PTT
|
Functional
(One stage method,clotting)
|
|
18
|
Factor X
|
7
|
NO
|
PT & PTT
|
Functional
(One stage method,clotting)
|
|
19
|
Factor IX
|
7
|
NO
|
PT & PTT
|
Functional
(One stage method,clotting)
|
|
20
|
Factor VIII
|
7
|
NO
|
PT & PTT
|
Functional
(One stage method,clotting)
|
|
21
|
Factor VII
|
7
|
NO
|
PT & PTT
|
Functional
(One stage method,clotting)
|
|
22
|
Factor V
|
7
|
NO
|
PT & PTT
|
Functional
(One stage method,clotting)
|
|
23
|
Factor II
|
7
|
NO
|
PT & PTT
|
Functional
(One stage method,clotting)
|
|
24
|
All Coagulation Factor Inhibitor
|
7
|
NO
|
PT & PTT
|
Semi qualitative
|
|
25
|
Hb A2
|
3
|
YES
|
CBC
|
Electrophoresis
&
Chromatography
|
|
26
|
Hb F
|
3
|
YES
|
CBC
|
Electrophoresis
&
Alkaline denaturation
|
|
27
|
Osmotic fragility
|
1
|
YES
|
Heparinized
(5cc)
|
Osmotic fragility
|
|
28
|
Cryohemolysate
|
1
|
YES
|
CBC
|
Photometric
|
|
29
|
Hame 's test
|
1
|
YES
|
CBC
And Clot
|
Modified acidified hames test
|
|
30
|
Sucrose hemolysis test
|
1
|
YES
|
CBC And Clot
|
Photometric
|
|
31
|
Unstable hemoglobin
|
1
|
YES
|
CBC
|
Turbidometric
|
|
32
|
Solubility test
|
1
|
YES
|
CBC
|
Turbidometric
|
|
33
|
Sickle Prep
|
1
|
YES
|
CBC
|
Microscopic
|
|
34
|
Hb Electrophoresis
|
3
|
YES
|
CBC
|
Alkaline electrophoresis
|
|
35
|
Hemoglobinopathies
|
3
|
YES
|
CBC
|
Alkaline electrophoresis
|
|
36
|
HbH
|
1
|
YES
|
CBC
|
Microscopic
|
|
37
|
LE cell
|
1
|
YES
|
DefibrinizedBlood
|
Standard Method
|
|
38
|
Cryoglobulin
|
1
|
YES
|
CBC
|
Standard Method
|
|
39
|
B12
|
1
|
YES
|
Clot
|
ECL
|
|
40
|
Folic Acid
|
1
|
YES
|
Clot
|
ECL
|
|
41
|
Erythropoietin (EPO)
|
30
|
NO
|
Clot
|
ELISA
|
|
42
|
Methhemoglobin
|
1
|
YES
|
CBC
|
Standard
Method
|
|
43
|
F V Leiden Mutation
|
1
|
YES
|
CBC
|
Reverse
Dot Blot PCR
|
|
44
|
F V mutation
|
1
|
YES
|
CBC
|
Reverse
Dot Blot PCR
|
|
45
|
F II mutation (prothrombin mutation)
|
1
|
YES
|
CBC
|
Reverse
Dot Blot PCR
|
|
46
|
MTHFR mutation
|
1
|
YES
|
CBC
|
Reverse
Dot Blot PCR
|
|
47
|
PAI Mutation
|
1
|
YES
|
CBC
|
Reverse
Dot Blot PCR
|
|
48
|
Complete thrombosis mutation panel
|
1
|
YES
|
CBC
|
Reverse
Dot Blot PCR
|
|
49
|
Pharmacogenetics of warfarin
|
2
|
YES
|
CBC
|
Reverse Dot Blot
|